This segment focuses on the research, development, and potential commercialization of monoclonal antibody-based therapies for cancer treatment. Omnimmune is developing monoclonal antibodies targeting human chorionic gonadotropin (hCG). The company utilizes advanced biotechnology and immunological techniques to identify, develop, and optimize these antibodies. The therapeutic approach aims to leverage passive immunization strategies. The segment's activities include preclinical studies, clinical trial planning, and regulatory submissions. The patient impact is focused on improving outcomes for cancer patients through targeted therapies. Market positioning involves competing with established pharmaceutical companies and emerging biotech firms in the oncology space. Future opportunities include expanding the antibody portfolio and exploring combination therapies. Regulatory aspects involve FDA approval processes and adherence to Good Manufacturing Practices (GMP).

This segment is dedicated to developing personalized cancer treatment strategies. Omnimmune intends to develop personalized cancer treatment with the selection of prophylactic and therapeutic vaccines (active immunization), monoclonal antibodies (passive immunization), and genomic-based products. The company is integrating complementary cancer therapeutic, diagnostic, and prognostic technologies. This involves genomic-based products and diagnostic tools to identify specific cancer markers and tailor treatments accordingly. The segment's research and development activities include biomarker discovery, assay development, and clinical trial design. The therapeutic areas covered include various types of cancer. The patient impact is focused on improving treatment efficacy and reducing side effects through personalized approaches. Market positioning involves competing with companies offering precision medicine solutions. Future opportunities include expanding the range of genomic-based products and diagnostic tests. Regulatory aspects involve FDA approval for diagnostics and therapeutics.